News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
474,732 Results
Type
Article (28970)
Company Profile (129)
Press Release (445623)
Multimedia
Podcasts (86)
Webinars (14)
Section
Business (133747)
Career Advice (592)
Deals (22681)
Drug Delivery (96)
Drug Development (58407)
Employer Resources (58)
FDA (9696)
Job Trends (8454)
News (228038)
Policy (20466)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (984)
Accelerated approval (34)
Adcomms (10)
Allergies (138)
Alliances (36356)
ALS (138)
Alzheimer's disease (956)
Antibody-drug conjugate (ADC) (356)
Approvals (10144)
Artificial intelligence (468)
Autoimmune disease (244)
Automation (36)
Bankruptcy (198)
Best Places to Work (6267)
BIOSECURE Act (9)
Biosimilars (182)
Biotechnology (60)
Bladder cancer (148)
Brain cancer (52)
Breast cancer (552)
Cancer (4230)
Cardiovascular disease (338)
Career advice (529)
Career pathing (15)
CAR-T (251)
CDC (18)
Celiac Disease (1)
Cell therapy (607)
Cervical cancer (32)
Clinical research (51890)
Collaboration (1551)
Company closure (1)
Compensation (819)
Complete response letters (57)
COVID-19 (2252)
CRISPR (84)
C-suite (865)
Cystic fibrosis (105)
Data (5791)
Decentralized trials (1)
Denatured (19)
Depression (107)
Dermatology (62)
Diabetes (332)
Diagnostics (3250)
Digital health (30)
Diversity (5)
Diversity, equity & inclusion (16)
Drug discovery (222)
Drug pricing (142)
Drug shortages (20)
Duchenne muscular dystrophy (166)
Earnings (49754)
Editorial (29)
Employer branding (5)
Employer resources (54)
Events (77892)
Executive appointments (877)
FDA (12310)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (17)
Funding (1231)
Gene editing (166)
Generative AI (36)
Gene therapy (433)
GLP-1 (662)
Government (2422)
Grass and pollen (7)
Guidances (300)
Healthcare (7247)
HIV (60)
Huntington's disease (32)
IgA nephropathy (86)
Immunology and inflammation (188)
Immuno-oncology (67)
Indications (156)
Infectious disease (2479)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (96)
Intellectual property (205)
Interviews (86)
IPO (8980)
IRA (35)
Job creations (2555)
Job search strategy (466)
JPM (36)
Kidney cancer (15)
Labor market (37)
Layoffs (281)
Leadership (12)
Legal (4935)
Liver cancer (66)
Longevity (16)
Lung cancer (549)
Lymphoma (404)
Machine learning (33)
Management (20)
Manufacturing (736)
MASH (167)
Medical device (3962)
Medtech (4012)
Mergers & acquisitions (14597)
Metabolic disorders (946)
mRNA (133)
Multiple sclerosis (150)
NASH (17)
Neurodegenerative disease (250)
Neuropsychiatric disorders (74)
Neuroscience (1974)
Neurotech (1)
NextGen: Class of 2026 (2656)
Non-profit (1126)
Now hiring (24)
Obesity (418)
Opinion (214)
Ovarian cancer (159)
Pain (187)
Pancreatic cancer (206)
Parkinson's disease (242)
Partnered (18)
Patents (413)
Patient recruitment (469)
Peanut (42)
People (47686)
Pharmaceutical (66)
Pharmacy benefit managers (23)
Phase 1 (15743)
Phase 2 (22880)
Phase 3 (17495)
Pipeline (6414)
Policy (181)
Postmarket research (1878)
Preclinical (6153)
Press Release (38)
Prostate cancer (227)
Psychedelics (26)
Radiopharmaceuticals (211)
Rare diseases (765)
Real estate (3744)
Recruiting (24)
Regulatory (16706)
Reports (20)
Research institute (1097)
Resumes & cover letters (73)
Rett syndrome (32)
RNA editing (15)
RSV (57)
Schizophrenia (119)
Series A (204)
Series B (227)
Service/supplier (3)
Sickle cell disease (88)
Special edition (13)
Spinal muscular atrophy (114)
Sponsored (22)
Startups (2838)
State (2)
Stomach cancer (9)
Supply chain (85)
Tariffs (77)
The Weekly (65)
Vaccines (693)
Venture capital (65)
Weight loss (248)
Women's health (76)
Worklife (4)
Date
Today (156)
Last 7 days (677)
Last 30 days (2501)
Last 365 days (21051)
2026 (8418)
2025 (21408)
2024 (21628)
2023 (22852)
2022 (30998)
2021 (33958)
2020 (31002)
2019 (21288)
2018 (16452)
2017 (22400)
2016 (23881)
2015 (28844)
2014 (22988)
2013 (19764)
2012 (20687)
2011 (20651)
2010 (18765)
Location
Africa (500)
Alabama (47)
Alaska (1)
Arizona (155)
Arkansas (11)
Asia (31834)
Australia (4613)
California (9005)
Canada (2726)
China (1043)
Colorado (411)
Connecticut (388)
Delaware (334)
Europe (69964)
Florida (1245)
Georgia (258)
Hawaii (3)
Idaho (23)
Illinois (790)
India (76)
Indiana (357)
Iowa (11)
Japan (445)
Kansas (100)
Kentucky (28)
Louisiana (20)
Maine (11)
Maryland (957)
Massachusetts (6544)
Michigan (149)
Minnesota (383)
Mississippi (2)
Missouri (82)
Montana (13)
Nebraska (11)
Nevada (106)
New Hampshire (28)
New Jersey (2658)
New Mexico (12)
New York (2295)
North Carolina (1170)
North Dakota (7)
Northern California (4610)
Ohio (218)
Oklahoma (10)
Oregon (24)
Pennsylvania (1566)
Puerto Rico (22)
Rhode Island (27)
South America (809)
South Carolina (21)
Southern California (3499)
Tennessee (96)
Texas (1430)
United States (31164)
Utah (148)
Virginia (289)
Washington D.C. (57)
Washington State (710)
West Virginia (2)
Wisconsin (111)
Wyoming (1)
474,732 Results for "modra pharmaceuticals b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
April 28, 2026
·
7 min read
Press Releases
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 15, 2025
·
3 min read
MASH
Madrigal picks up another siRNA asset for MASH, betting up to $1B with Arrowhead
Madrigal Pharmaceuticals has licensed from Arrowhead Pharmaceuticals an RNA interference candidate that targets a genetic mutation present in around 30% of patients with MASH.
May 5, 2026
·
2 min read
·
Tristan Manalac
Deals
Sun Pharma beams up Organon in $11.75B acquisition
Sun Pharmaceutical is bringing Merck spinoff Organon into the fold, paying $11.75 billion in hopes of becoming a top global biosimilar player.
April 27, 2026
·
1 min read
·
Gabrielle Masson
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
Catalyst Pharmaceuticals comes with a trio of approved drugs as Angelini Pharma expands its neuroscience offerings.
May 7, 2026
·
2 min read
·
Gabrielle Masson
Policy
Modra Pharmaceuticals Announces U.S. Patent Issuance for ModraDoc006/r
Modra Pharmaceuticals announced that the U.S. Patent and Trademark Office has issued to Modra U.S. Patent No. 11,571,408, covering the use of its oral taxane therapeutic ModraDoc006/r. ModraDoc006/r is an oral tablet formulation of docetaxel co-administered with ritonavir, a boosting agent that enhances bioavailability.
March 16, 2023
·
2 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
Palleon Pharmaceuticals Presents First-in-Class B7-H3 Targeted Sialidase at the 2026 AACR Annual Meeting
April 20, 2026
·
3 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
April 9, 2026
·
2 min read
Press Releases
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
April 27, 2026
·
9 min read
1 of 47,474
Next
